NewsRx

Search our medical news database

Surgical Technology

Loupe-assisted technique more efficient and cost-effective than microsurgery

Published in Women's Health Weekly, December 1st, 2005

Loupe-assisted vasectomy reversal is more efficient and cost-effective than microsurgery, with no significant drawbacks.

A group of surgeons in Taiwan conducted a study "to compare the outcome of loupe-assisted, modified one-layer vasovasostomy (MOLV) and conventional microsurgical MOLV for vasectomy reversal."

"We retrospectively analyzed data for 74 patients who had a MOLV between 1993 and 2003," explained M.L. Hsieh and coauthors at Chang Gung Memorial Hospital. Of the 74 patients studied, "42 had the standard microsurgical (x 10-16) MOLV (group 1, mean age 40.5 years, SD 6.3, range 30-58) and 32 had a loupe-assisted (x 3) MOLV (group 2, mean age...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook